These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 15640538)

  • 1. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant therapy for percutaneous coronary intervention.
    Rao SV; Ohman EM
    Circ Cardiovasc Interv; 2010 Feb; 3(1):80-8. PubMed ID: 20160186
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of heparin and related drugs.
    Hemker HC; Beguin S
    Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor.
    Cella G; Girolami A; Sasahara AA
    Circulation; 1999 Jun; 99(25):3323. PubMed ID: 10385510
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombin].
    Camici M; Sagripanti A; Di Mitri R
    Minerva Med; 2000; 91(5-6):105-12. PubMed ID: 11084844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors.
    Kokolis S; Cavusoglu E; Clark LT; Marmur JD
    Prog Cardiovasc Dis; 2004; 46(6):506-23. PubMed ID: 15224257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological rationale for the therapeutic role of specific antithrombins.
    Weitz JI
    Coron Artery Dis; 1996 Jun; 7(6):409-19. PubMed ID: 8889356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.
    Harenberg J; Zokai K; Piazolo L; Fenyvesi T; Jörg I
    Semin Thromb Hemost; 2002 Aug; 28(4):379-82. PubMed ID: 12244485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct versus indirect thrombin inhibition in percutaneous coronary intervention.
    Marmur JD
    J Invasive Cardiol; 2002 Apr; 14 Suppl B():8B-18B. PubMed ID: 11967386
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct thrombin inhibitors: pharmacology and clinical relevance.
    Kam PC; Kaur N; Thong CL
    Anaesthesia; 2005 Jun; 60(6):565-74. PubMed ID: 15918828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT; Paul W; Emerson M; Cicala C; Page CP
    Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The search for replacements for unfractionated heparin.
    Antman EM
    Circulation; 2001 May; 103(18):2310-4. PubMed ID: 11342482
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of direct thrombin inhibitors in comparison with glycosaminoglycans.
    Markwardt F
    Semin Thromb Hemost; 2001 Oct; 27(5):523-30. PubMed ID: 11668423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current aspects of antithrombotic therapy].
    Bŭcharova V
    Vutr Boles; 1990; 29(3):14-20. PubMed ID: 2178290
    [No Abstract]   [Full Text] [Related]  

  • 18. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antithrombin-based anticoagulants.
    Desai UR
    Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ; Sanderson PE
    Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.